Taub Rebecca sold MDGL
January 9, 2026 · Form 4 insider transaction
Taub Rebecca sold 970 shares of Madrigal Pharmaceuticals, Inc. at $518.67 per share, a transaction worth $503.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
970
Price
$518.67
Total value
$503.1K
InsiderTaub Rebecca
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after466,029
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.39 to $519.29, inclusive.